Cellini, Numa
 Distribuzione geografica
Continente #
EU - Europa 4.405
NA - Nord America 3.943
AS - Asia 2.804
SA - Sud America 505
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 11.757
Nazione #
US - Stati Uniti d'America 3.868
DE - Germania 2.262
SG - Singapore 1.288
CN - Cina 813
SE - Svezia 605
UA - Ucraina 422
BR - Brasile 421
FR - Francia 288
GB - Regno Unito 196
VN - Vietnam 180
IT - Italia 159
IE - Irlanda 127
IN - India 107
FI - Finlandia 100
RU - Federazione Russa 92
ID - Indonesia 87
TR - Turchia 77
JP - Giappone 66
CA - Canada 34
HK - Hong Kong 31
BD - Bangladesh 28
AR - Argentina 26
NL - Olanda 25
IQ - Iraq 24
BE - Belgio 22
CZ - Repubblica Ceca 19
MX - Messico 19
PL - Polonia 19
CI - Costa d'Avorio 18
EC - Ecuador 15
ES - Italia 15
ZA - Sudafrica 15
VE - Venezuela 12
PK - Pakistan 11
AT - Austria 10
CO - Colombia 10
EG - Egitto 10
LT - Lituania 10
MA - Marocco 10
SA - Arabia Saudita 10
PH - Filippine 9
IR - Iran 8
KE - Kenya 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 6
CL - Cile 6
EU - Europa 6
JM - Giamaica 6
UY - Uruguay 6
UZ - Uzbekistan 6
AL - Albania 5
IL - Israele 5
JO - Giordania 5
LK - Sri Lanka 5
NP - Nepal 5
AM - Armenia 4
AU - Australia 4
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
KZ - Kazakistan 4
LU - Lussemburgo 4
SN - Senegal 4
SY - Repubblica araba siriana 4
GA - Gabon 3
MY - Malesia 3
NI - Nicaragua 3
PY - Paraguay 3
RO - Romania 3
AG - Antigua e Barbuda 2
AZ - Azerbaigian 2
BZ - Belize 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
Totale 11.744
Città #
Singapore 685
Chandler 565
Ashburn 437
San Jose 316
Jacksonville 222
San Mateo 173
Nanjing 143
Beijing 136
Nürnberg 136
Dublin 126
Dearborn 105
The Dalles 91
Wilmington 85
Ann Arbor 82
Jakarta 80
Woodbridge 76
Lauterbourg 72
Boston 69
Los Angeles 68
New York 66
Nanchang 64
Hefei 63
Munich 63
Izmir 58
Ho Chi Minh City 56
Bremen 54
Lawrence 53
Frankfurt am Main 51
São Paulo 51
Hanoi 48
Houston 48
Moscow 48
Tokyo 45
Fairfield 43
Marseille 43
Leawood 37
Dallas 35
Redwood City 33
Seattle 33
Milan 32
Fremont 31
Hong Kong 29
Kunming 28
University Park 28
Jiaxing 27
Shenyang 25
Brussels 22
Santa Clara 22
Hebei 21
Princeton 21
Rome 21
Buffalo 20
Abidjan 18
Kent 18
Lancaster 18
Norwalk 18
Auburn Hills 16
Changsha 16
Detroit 15
Mountain View 15
Shanghai 15
Tianjin 15
Bexley 14
Hangzhou 14
Helsinki 14
Paris 14
Turku 14
Orem 12
Redmond 12
Zhengzhou 12
Amsterdam 11
Cambridge 11
Chicago 11
Guangzhou 11
Rio de Janeiro 11
San Francisco 11
Boardman 10
Düsseldorf 10
London 10
Mumbai 10
Stockholm 10
Wroclaw 10
Atlanta 9
Brooklyn 9
Cattolica 9
Denver 9
Las Vegas 9
Santo André 9
Chennai 8
Haiphong 8
Portsmouth 8
Belo Horizonte 7
Changchun 7
Johannesburg 7
Lanzhou 7
Manchester 7
Mexico City 7
Montreal 7
Ningbo 7
Simi Valley 7
Totale 5.523
Nome #
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 310
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 228
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 227
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 225
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 222
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 215
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 209
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 201
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 201
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 199
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 192
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 191
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 189
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 188
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 187
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 187
Phase I trial of weekly gemcitabin and concurrent radiotherapy in patients with inoperable non small cell lung cancer. 184
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 183
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 182
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 181
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 181
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 178
Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine. 176
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 175
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 174
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 174
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 173
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 170
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 169
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 168
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 167
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 164
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 164
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 159
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 158
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 157
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 154
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 152
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 151
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 151
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 150
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 148
Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study 148
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 146
Chemoradiation therapy and IORT in locally advanced rectal cancer: preliminary results in 36 patients 141
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 140
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 140
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 139
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 139
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 138
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 136
Virtual simulation:fifteen years later 134
Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation 133
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 133
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 131
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 130
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 125
Whole liver intraoperative irradiation after partial hepatectomy produces minimal functional and pathologic lesions 121
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 119
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 117
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 117
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 110
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 109
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 103
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 98
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 96
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 95
The role of computed tomography in defining the target volume for the integrated therapy of orbital epitheliomas 93
INTERMITTENT INTRATHECAL METHOTREXATE AND FRACTIONAL RADIATION (M-IMFRA) PLUS CHEMOTHERAPY IN CHILDHOOD LEUKEMIA 92
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a phase i study. 91
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 90
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). 89
Scientific committee. multidisciplinary rectal cancer management: 2nd european rectal cancer consensus conference (eureca-cc2). 74
Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. 63
The prognostic effect of clinical staging in pancreatic adenocarcinoma 53
High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful? 51
Totale 11.841
Categoria #
all - tutte 41.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 0 124 26
2021/2022820 73 91 10 69 77 19 13 120 31 39 122 156
2022/20231.501 206 210 112 248 95 185 75 123 159 15 51 22
2023/2024578 28 171 13 41 14 57 25 52 5 15 100 57
2024/20251.421 45 36 96 42 164 30 25 77 258 151 258 239
2025/20263.137 523 136 204 329 568 164 509 188 252 227 37 0
Totale 11.841